Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity, Med. Chem. Commun., 2010, 1, 287. Broadband terahertz time-domain spectroscopy of drugs-of-abuse and the use of principal component analysis, Analyst, 2009, 134, 1658. Determination of amphetamine-type stimulants, cocaine and ketamine in human hair by liquid chromatography/linear ion trap–Orbitrap hybrid mass spectrometry, Analyst, 2011, 136, 3503. Organic impurities, stable isotopes, or both: A comparison of instrumental and pattern recognition techniques for the profiling of 3,4-methylenedioxymethamphetamine, Anal. Methods, 2011, 3, 2279. Modification of Ag nanoparticles with mixed thiols for improved SERS detection of poorly adsorbing target molecules: detection of MDMA, Chem. Commun., 2011, 47, 4523. A one year investigation of the occurrence of illicit drugs in wastewater from Brussels, Belgium, J. Environ. Monit., 2011, 13, 1008. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities, Integr. Biol., 2011, 3, 422. Effective complexation of psychotropic phenethylammonium salts from a disodium dipyrazolate salt of macrocyclic structure, J. Chem. Soc., Perkin Trans. 2, 2002, 0, 1634. A convenient biomimetic synthesis of optically active putative neurotoxic metabolites of MDMA (“ecstasy?) from R-(-)- and S-(+)-N-methyl-a-methyldopamine precursors, Org. Biomol. Chem., 2012, 10, 3739.